Literature DB >> 15986196

Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat.

Letizia Antonilli1, Emma Petecchia, Daniele Caprioli, Aldo Badiani, Paolo Nencini.   

Abstract

RATIONALE: Heroin is rapidly metabolized to morphine that in turn is transformed in morphine-3-glucuronide (M3G), an inactive metabolite, and morphine-6-glucuronide (M6G), a potent mu-opioid receptor (MOR) agonist. We have found that heroin addicts exhibit higher M6G/M3G ratios relative to morphine-treated control subjects. We have also shown that heroin-treated rats exhibit measurable levels of M6G (which is usually undetectable in this species) and reduced levels of M3G.
OBJECTIVE: We investigated the role of MOR in these effects of heroin, by examining the effects of methadone, a MOR agonist, and of naltrexone, a MOR antagonist, on morphine glucuronidation. We also investigated the effects of alcohol, which is known to alter drug metabolism and is frequently coabused by heroin addicts.
METHODS: Morphine glucuronidation was studied in liver microsomes obtained from rats exposed daily for 10 days to saline, heroin (10 mg/kg, i.p.), naltrexone (20-40 mg/kg, i.p.), heroin + naltrexone (10 mg/kg+20-40 mg/kg, i.p.), methadone (5-20 mg/kg, i.p.), or 10% ethanol.
RESULTS: Heroin induced the synthesis of M6G and decreased the synthesis of M3G. Naltrexone exhibited intrinsic modulatory activity on morphine glucuronidation, increasing the synthesis of M3G via a low-affinity/high-capacity reaction characterized by positive cooperativity. The rate of M3G synthesis in the heroin + naltrexone groups was not different from that of the naltrexone groups. Methadone and ethanol induced a modest increase in M3G synthesis and had no effect on M6G synthesis.
CONCLUSION: The effects of heroin on morphine glucuronidation are not shared by methadone or alcohol (two drugs that figure prominently in the natural history of heroin addiction) and do not appear to depend on the activation of MOR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986196     DOI: 10.1007/s00213-005-0030-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection.

Authors:  E L Schwartz; A B Brechbühl; P Kahl; M A Miller; P A Selwyn; G H Friedland
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

Review 2.  Clinical and toxicological consequences of the inductive potential of ethanol.

Authors:  U Klotz; E Ammon
Journal:  Eur J Clin Pharmacol       Date:  1998-03       Impact factor: 2.953

Review 3.  Morphine metabolites.

Authors:  L L Christrup
Journal:  Acta Anaesthesiol Scand       Date:  1997-01       Impact factor: 2.105

4.  Metal contamination in illicit samples of heroin.

Authors:  F Infante; E Domínguez; D Trujillo; A Luna
Journal:  J Forensic Sci       Date:  1999-01       Impact factor: 1.832

5.  Selective induction of rat liver phase II enzymes by N-heterocycle analogues of phenanthrene: a response exhibiting high correlation between UDP-glucuronosyltransferase and microsomal epoxide hydrolase activities.

Authors:  M R Franklin; M H Slawson; D E Moody
Journal:  Xenobiotica       Date:  1993-03       Impact factor: 1.908

6.  High levels of morphine-6-glucuronide in street heroin addicts.

Authors:  Letizia Antonilli; Federico Semeraro; Carmen Suriano; Luciano Signore; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

7.  Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.

Authors:  Ingolf Meineke; Stefan Freudenthaler; Ute Hofmann; Elke Schaeffeler; Gerd Mikus; Matthias Schwab; Hilmar W Prange; Christoph H Gleiter; J Brockmöller
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

8.  Effects of naltrexone on pharmacodynamics and pharmacokinetics of intravenously administered morphine in the rat.

Authors:  H N Bhargava; N H Rahmani; V M Villar; A K Larsen
Journal:  Pharmacology       Date:  1993       Impact factor: 2.547

9.  Use of morphine and 6-monoacetylmorphine in blood for the evaluation of possible risk factors for sudden death in 192 heroin users.

Authors:  Anna Fugelstad; Johan Ahlner; Lena Brandt; Gunnel Ceder; Staffan Eksborg; Jovan Rajs; Olof Beck
Journal:  Addiction       Date:  2003-04       Impact factor: 6.526

10.  Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.

Authors:  C B Trapnell; R W Klecker; C Jamis-Dow; J M Collins
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  7 in total

1.  Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat.

Authors:  Maria Meringolo; Valentina Brusadin; Maria T De Luca; Christian Montanari; Christian L Montanari; Letizia Antonilli; Paolo Nencini; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2011-10-21       Impact factor: 4.530

Review 2.  Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.

Authors:  Caroline A Arout; Ellen Edens; Ismene L Petrakis; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

3.  Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats.

Authors:  M D Raleigh; M Pravetoni; A C Harris; A K Birnbaum; P R Pentel
Journal:  J Pharmacol Exp Ther       Date:  2012-12-07       Impact factor: 4.030

4.  Morphine induces hyperalgesia without involvement of μ-opioid receptor or morphine-3-glucuronide.

Authors:  Maarten Swartjes; René A G Mooren; Amanda R Waxman; Caroline Arout; Koen van de Wetering; Jan den Hartigh; Jos H Beijnen; Benjamin Kest; Albert Dahan
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

5.  Attenuated effects of experimenter-administered heroin in adolescent vs. adult male rats: physical withdrawal and locomotor sensitization.

Authors:  James M Doherty; Kyle J Frantz
Journal:  Psychopharmacology (Berl)       Date:  2012-09-02       Impact factor: 4.530

6.  Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats.

Authors:  Michael D Raleigh; Paul R Pentel; Mark G LeSage
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

7.  Ultrasonic vocalization in rats self-administering heroin and cocaine in different settings: evidence of substance-specific interactions between drug and setting.

Authors:  Riccardo Avvisati; Laura Contu; Emiliana Stendardo; Caterina Michetti; Christian Montanari; Maria Luisa Scattoni; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2016-03-10       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.